Lenvatinib bulk supplier for pharma manufacturers

Lenvatinib 4 / 10 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 4 / 10 mg

Reference Brands: Lenvima (US/EU)

Category: Oncology Cancer Care

Lenvatinib is used in the treatment of thyroid cancer.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Lenvatinib? List it or send an offer →

Product Description:

Lenvatinib inhibits all three VEGF receptors, the four FGF receptors, PDGFR-alpha, KIT and RET. Breadth is its defining feature. Blocking VEGF alone tends to fail because tumours switch to fibroblast growth factor signalling to rebuild their blood supply; covering both pathways at once closes that route, which is why lenvatinib produces response rates in thyroid cancer far above anything achieved before it.

It is used for radioactive iodine-refractory differentiated thyroid cancer, for hepatocellular carcinoma as first-line treatment, for advanced renal cell carcinoma with everolimus or pembrolizumab, and for endometrial carcinoma with pembrolizumab. Toxicity is considerable and dose interruption is routine rather than exceptional: hypertension appears within days and needs treatment ready in advance, along with diarrhoea, fatigue, weight loss, proteinuria, hand-foot skin reaction and hypothyroidism. Arterial thromboembolic events, haemorrhage and fistula formation are serious risks.

Sourcing notes. Originator product in most territories, with generic entry beginning in a few — confirm per destination. The two capsule strengths combine to make every dose level, so both are needed for a treatment course, not just the higher one. No companion test required. Oral capsules, room temperature.

Lenvatinib — third party manufacturing & bulk supply

Lenvatinib 4 / 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lenvatinib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lenvatinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lenvatinib →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Lenvatinib is listed as Capsules in 4 / 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Lenvatinib is referenced against Lenvima (US/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.